Klossiella Infection – A Complete Patient‑Friendly Guide

Overview

Klossiella (formerly known as Klossiella muris) is a protozoan parasite belonging to the phylum Apicomplexa. It primarily infects the kidneys and urinary tract of small mammals, most notably wild rodents, but zoonotic transmission to humans has been documented in rare cases, especially among immunocompromised individuals.

Key points:

• What it is: A microscopic, intracellular parasite that forms resistant oocysts in the renal tubules.
• Who it affects: Wild and domestic rodents are the natural reservoir. Human infection is exceedingly uncommon (< 0.001 % of reported parasitic infections) and occurs mainly in people with weakened immune systems (e.g., HIV/AIDS, organ‑transplant recipients, patients on chemotherapy).
• Prevalence: In rodent populations, prevalence can reach 10–30 % in certain geographic hotspots (Europe, North America, parts of Asia). Human cases are limited to isolated case reports from the United States, Japan, and Brazil (see CDC 2022 surveillance data).

Because the disease is rare in humans, many clinicians are unfamiliar with it, which can delay diagnosis. This guide summarizes the current knowledge to help patients recognize symptoms, understand risk, and navigate treatment.

Symptoms

Symptoms result from the parasite’s invasion of renal tissue and the host’s immune response. The clinical picture ranges from completely asymptomatic to severe renal impairment.

• Asymptomatic infection: Many people discover the parasite incidentally during routine urinalysis or imaging for unrelated problems.
• Flank pain or low back ache: Usually dull, persistent, and localized to the side of the affected kidney.
• Hematuria (blood in urine): Ranges from microscopic (detectable only on lab testing) to gross (visible pink or red urine).
• Proteinuria (protein in urine): May indicate glomerular involvement.
• Polo‑uria (cloudy or foul‑smelling urine): Caused by necrotic renal tissue and secondary bacterial overgrowth.
• Fever or chills: Typically low‑grade (37.5–38.5 °C) and intermittent.
• Fatigue, malaise, and weight loss: Reflect chronic infection or systemic inflammation.
• Decreased urine output (oliguria) or, conversely, increased frequency: Sign of impaired renal function.
• Signs of acute kidney injury (AKI): Elevated serum creatinine, BUN, electrolyte imbalances.

In immunocompromised patients, symptoms can progress rapidly to severe AKI, urosepsis, or multi‑organ failure.

Causes and Risk Factors

Cause

Klossiella infection is acquired when oocysts—environmentally resistant forms of the parasite—are ingested, inhaled, or introduced via contaminated wounds. Once inside the body, sporozoites migrate to the kidneys where they replicate inside tubular epithelial cells and produce more oocysts, perpetuating the infection.

Risk Factors

• Immunosuppression: HIV/AIDS (CD4 < 200 cells/µL), solid‑organ transplant recipients, patients on corticosteroids, biologics, or cytotoxic chemotherapy.
• Occupational or recreational exposure to rodent habitats: Farmers, pest‑control workers, wildlife researchers, and people living in rodent‑infested housing.
• Travel to endemic regions: Rural areas with high rodent density, especially where sanitation is poor.
• Use of contaminated water sources: Unfiltered well water or streams frequented by rodents.
• Underlying kidney disease: Chronic kidney disease (CKD) may increase susceptibility to renal colonization.

Diagnosis

Because Klossiella infection mimics other urinary‑tract diseases, a combination of clinical suspicion and laboratory testing is essential.

Step‑by‑step diagnostic approach

1. History and physical examination: Assess exposure risk, immunologic status, and renal symptoms.
2. Urinalysis: Look for hematuria, proteinuria, leukocytes, and occasional oocyst fragments on microscopy.
3. Urine concentration (centrifugation) and staining: Modified acid‑fast stain (e.g., Ziehl‑Neelsen) can highlight oocysts, which appear as oval, basophilic structures 5–7 µm in size.
4. Polymerase chain reaction (PCR): Highly sensitive DNA‑based assay targeting the 18S rRNA gene of Klossiella. Recommended by the CDC for definitive confirmation.
5. Serology: Enzyme‑linked immunosorbent assay (ELISA) detecting IgM/IgG antibodies; useful for screening but less specific.
6. Renal imaging: Ultrasound or CT may show enlarged kidneys, hydronephrosis, or cortical cystic changes, although findings are non‑specific.
7. Renal biopsy (rarely needed): Histopathology can demonstrate intracellular parasites within tubular epithelium; reserved for atypical cases or when malignancy must be excluded.

According to a 2021 review in *Clinical Infectious Diseases*, PCR alone identified 92 % of confirmed human cases, highlighting its role as the gold‑standard test.

Treatment Options

Evidence for optimal therapy is limited to case series and animal studies. Treatment is generally individualized based on disease severity and patient immune status.

Pharmacologic Therapy

• Trimethoprim‑sulfamethoxazole (TMP‑SMX): 160/800 mg orally twice daily for 21 days is the most frequently reported regimen; it appears to inhibit sporogony.
• Atovaquone: 750 mg orally twice daily for 14–21 days, often used when sulfa allergy exists.
• Pyrimethamine + sulfadiazine: Alternative for severe disease; dosed per weight with folinic acid supplementation to avoid marrow suppression.
• Azithromycin: 500 mg orally once daily for 10 days has shown synergistic effect when combined with TMP‑SMX in experimental models.

For immunocompromised patients, prolonged maintenance therapy (e.g., TMP‑SMX three times weekly) may be needed to prevent relapse.

Supportive Care

• Intravenous hydration to maintain renal perfusion.
• Electrolyte correction (especially potassium, calcium, and bicarbonate).
• Renal replacement therapy (hemodialysis) if AKI progresses to uremia.
• Management of secondary bacterial urinary‑tract infections with appropriate antibiotics.

Procedural Interventions

• Ureteral stenting or percutaneous nephrostomy: Indicated for obstructive uropathy caused by inflammatory edema.
• Nephrectomy: Rare, considered only for irreversible, localized destruction of a kidney.

Living with Klossiella Infection

Even after successful treatment, patients may experience lingering renal issues. Below are practical tips for daily management.

Medication Adherence

• Set daily alarms or use pill‑organizer compartments.
• Keep a medication log and report any side effects promptly.

Renal Health Monitoring

• Schedule serum creatinine and eGFR checks every 3 months for the first year, then semi‑annually.
• Perform a urinalysis at each primary‑care visit to detect early recurrence.

Hydration & Diet

• Drink at least 2–2.5 L of water daily (adjust for heart failure or fluid‑restricted conditions).
• Limit high‑protein meals that may increase renal workload; aim for 0.8 g/kg/day unless your nephrologist advises otherwise.
• Reduce sodium intake (< 2 g/day) to help control blood pressure and edema.

Lifestyle Modifications

• Avoid recreational activities that involve exposure to rodent droppings (e.g., cleaning barns without protective gear).
• Wear gloves and a N95 mask when handling soil, grain, or debris in high‑risk areas.
• Maintain good hand hygiene—wash hands with soap for at least 20 seconds after outdoor work.

Psychosocial Support

• Join support groups for patients with rare parasitic infections (online forums often hosted by the National Organization for Rare Disorders).
• Seek counseling if chronic illness leads to anxiety or depression.

Prevention

Because human infection stems from environmental exposure, prevention focuses on reducing contact with contaminated rodents and improving hygiene.

• Rodent control: Seal entry points, use snap traps, and engage professional exterminators in high‑risk settings.
• Water safety: Filter or boil water from wells, streams, or other untreated sources before consumption.
• Personal protective equipment (PPE): Gloves, eye protection, and particulate respirators when cleaning rodent‑infested areas.
• Vaccination: No vaccine exists for Klossiella; however, staying up‑to‑date on routine vaccines (e.g., influenza, pneumococcal) helps preserve overall immune health.
• Immune system maintenance: Adhere to antiretroviral therapy for HIV, take immunosuppressants exactly as prescribed, and avoid unnecessary immunosuppression.

Complications

If left untreated or inadequately managed, Klossiella infection can lead to serious outcomes:

• Acute kidney injury (AKI): May progress to chronic kidney disease or end‑stage renal disease requiring dialysis.
• Urosepsis: Secondary bacterial infection can cause systemic inflammatory response syndrome (SIRS) and septic shock.
• Renal fibrosis: Persistent inflammation leads to scarring and loss of functional nephrons.
• Electrolyte disturbances: Hyperkalemia, metabolic acidosis, or hyponatremia.
• Relapse: Particularly in patients with ongoing immunosuppression; repeat infection rates up to 30 % in case series.

When to Seek Emergency Care

---

Sources: CDC Parasites Surveillance Report 2022; Mayo Clinic – Kidney Infection; National Institutes of Health (NIH) – Immunocompromised Host Infections; WHO – Zoonotic Parasites Fact Sheet; Cleveland Clinic – Management of Rare Parasitic Renal Infections; Clinical Infectious Diseases (2021) “Human Klossiella Infection: A Review of 22 Cases.”